IlluminOss Medical receives conditional FDA approval for clinical trial

EAST PROVIDENCE – IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. IlluminOss Medical, a privately held, commercial medical device company that focuses on minimally invasive orthopedic fracture repair, said that it…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -